Recurrence of primary disease in children after renal transplantation: an evidence-based update

Area of Science:

• Nephrology
• Transplantation Immunology
• Clinical Medicine

Background:

• Advances in anti-rejection therapy have decreased acute cellular rejection rates in early post-renal transplant periods.
• Recurrence of primary kidney disease in the allograft has emerged as a significant cause of morbidity and graft loss.
• Current management strategies for recurrent primary disease are largely based on limited evidence from case series.

Purpose of the Study:

• To review the existing literature on the recurrence of primary diseases after renal transplantation.
• To identify current challenges and gaps in knowledge regarding this complication.
• To highlight areas for future research, emphasizing the need for robust clinical trials.

Main Methods:

• A comprehensive survey of published literature was conducted.
• The review focused on studies addressing primary disease recurrence post-renal transplant.
• Analysis of existing reports to assess current understanding and management practices.

Main Results:

• The incidence of acute cellular rejection has decreased due to improved anti-rejection therapies.
• Recurrence of primary kidney diseases is increasingly recognized as a major threat to long-term graft survival.
• Current management is primarily guided by observational data, lacking high-level evidence.

Conclusions:

• The shift in post-transplant complications necessitates a greater focus on managing recurrent primary diseases.
• There is a critical need for well-designed, randomized, multicenter clinical trials to establish effective therapeutic strategies.
• Future research should focus on mechanistic understanding and evidence-based treatment protocols for recurrent kidney diseases post-transplant.